Final  ||| S:0 E:6 ||| JJ
report  ||| S:6 E:13 ||| NN
of  ||| S:13 E:16 ||| IN
the  ||| S:16 E:20 ||| DT
Cosmetic  ||| S:20 E:29 ||| NNP
Ingredient  ||| S:29 E:40 ||| NNP
Review  ||| S:40 E:47 ||| NNP
Expert  ||| S:47 E:54 ||| NNP
Panel  ||| S:54 E:60 ||| NNP
amended  ||| S:60 E:68 ||| VBD
safety  ||| S:68 E:75 ||| NN
assessment  ||| S:75 E:86 ||| NN
of  ||| S:86 E:89 ||| IN
Calendula  ||| S:89 E:99 ||| NNP
officinalis-derived  ||| S:99 E:119 ||| FW
cosmetic  ||| S:119 E:128 ||| FW
ingredients  ||| S:128 E:140 ||| FW
Calendula  ||| S:140 E:150 ||| FW
officinalis  ||| S:150 E:162 ||| FW
extract ||| S:162 E:169 ||| FW
,  ||| S:169 E:171 ||| ,
C  ||| S:171 E:173 ||| NNP
officinalis  ||| S:173 E:185 ||| JJ
flower ||| S:185 E:191 ||| NN
,  ||| S:191 E:193 ||| ,
C  ||| S:193 E:195 ||| NNP
officinalis  ||| S:195 E:207 ||| FW
flower  ||| S:207 E:214 ||| FW
extract ||| S:214 E:221 ||| FW
,  ||| S:221 E:223 ||| ,
C  ||| S:223 E:225 ||| NNP
officinalis  ||| S:225 E:237 ||| JJ
flower  ||| S:237 E:244 ||| NN
oil ||| S:244 E:247 ||| NN
,  ||| S:247 E:249 ||| ,
and  ||| S:249 E:253 ||| CC
C  ||| S:253 E:255 ||| $
officinalis  ||| S:255 E:267 ||| CD
seed  ||| S:267 E:272 ||| NN
oil  ||| S:272 E:276 ||| NN
are  ||| S:276 E:280 ||| VBP
cosmetic  ||| S:280 E:289 ||| JJ
ingredients  ||| S:289 E:301 ||| NNS
derived  ||| S:301 E:309 ||| VBN
from  ||| S:309 E:314 ||| IN
C  ||| S:314 E:316 ||| $
officinalis ||| S:316 E:327 ||| CD
.  ||| S:327 E:329 ||| .
These  ||| S:329 E:335 ||| DT
ingredients  ||| S:335 E:347 ||| NNS
may  ||| S:347 E:351 ||| MD
contain  ||| S:351 E:359 ||| VB
minerals ||| S:359 E:367 ||| NNS
,  ||| S:367 E:369 ||| ,
carbohydrates ||| S:369 E:382 ||| NN
,  ||| S:382 E:384 ||| ,
lipids ||| S:384 E:390 ||| NN
,  ||| S:390 E:392 ||| ,
phenolic  ||| S:392 E:401 ||| JJ
acids ||| S:401 E:406 ||| NNS
,  ||| S:406 E:408 ||| ,
flavonoids ||| S:408 E:418 ||| NN
,  ||| S:418 E:420 ||| ,
tannins ||| S:420 E:427 ||| NN
,  ||| S:427 E:429 ||| ,
coumarins ||| S:429 E:438 ||| NN
,  ||| S:438 E:440 ||| ,
sterols  ||| S:440 E:448 ||| NN
and  ||| S:448 E:452 ||| CC
steroids ||| S:452 E:460 ||| NNS
,  ||| S:460 E:462 ||| ,
monoterpenes ||| S:462 E:474 ||| NN
,  ||| S:474 E:476 ||| ,
sesquiterpenes ||| S:476 E:490 ||| NN
,  ||| S:490 E:492 ||| ,
triterpenes ||| S:492 E:503 ||| NN
,  ||| S:503 E:505 ||| ,
tocopherols ||| S:505 E:516 ||| NN
,  ||| S:516 E:518 ||| ,
quinones ||| S:518 E:526 ||| NN
,  ||| S:526 E:528 ||| ,
amino  ||| S:528 E:534 ||| JJ
acids ||| S:534 E:539 ||| NNS
,  ||| S:539 E:541 ||| ,
and  ||| S:541 E:545 ||| CC
resins ||| S:545 E:551 ||| NNS
.  ||| S:551 E:553 ||| .
These  ||| S:553 E:559 ||| DT
ingredients  ||| S:559 E:571 ||| NNS
were  ||| S:571 E:576 ||| VBD
not  ||| S:576 E:580 ||| RB
significantly  ||| S:580 E:594 ||| RB
toxic  ||| S:594 E:600 ||| JJ
in  ||| S:600 E:603 ||| IN
single-dose  ||| S:603 E:615 ||| JJ
oral  ||| S:615 E:620 ||| JJ
studies  ||| S:620 E:628 ||| NNS
using  ||| S:628 E:634 ||| VBG
animals ||| S:634 E:641 ||| NNS
.  ||| S:641 E:643 ||| .
The  ||| S:643 E:647 ||| DT
absence  ||| S:647 E:655 ||| NN
of  ||| S:655 E:658 ||| IN
reproductive ||| S:658 E:670 ||| CD
/ ||| S:670 E:671 ||| CD
developmental  ||| S:671 E:685 ||| CD
toxicity  ||| S:685 E:694 ||| NNS
was  ||| S:694 E:698 ||| VBD
inferred  ||| S:698 E:707 ||| VBN
from  ||| S:707 E:712 ||| IN
repeat-dose  ||| S:712 E:724 ||| JJ
studies  ||| S:724 E:732 ||| NNS
of  ||| S:732 E:735 ||| IN
coriander  ||| S:735 E:745 ||| JJ
oil ||| S:745 E:748 ||| NN
,  ||| S:748 E:750 ||| ,
with  ||| S:750 E:755 ||| IN
a  ||| S:755 E:757 ||| DT
similar  ||| S:757 E:765 ||| JJ
composition ||| S:765 E:776 ||| NN
.  ||| S:776 E:778 ||| .
Overall ||| S:778 E:785 ||| RB
,  ||| S:785 E:787 ||| ,
these  ||| S:787 E:793 ||| DT
ingredients  ||| S:793 E:805 ||| NNS
were  ||| S:805 E:810 ||| VBD
not  ||| S:810 E:814 ||| RB
genotoxic ||| S:814 E:823 ||| VBN
.  ||| S:823 E:825 ||| .
They  ||| S:825 E:830 ||| PRP
also  ||| S:830 E:835 ||| RB
were  ||| S:835 E:840 ||| VBD
not  ||| S:840 E:844 ||| RB
irritating ||| S:844 E:854 ||| JJ
,  ||| S:854 E:856 ||| ,
sensitizing ||| S:856 E:867 ||| NN
,  ||| S:867 E:869 ||| ,
or  ||| S:869 E:872 ||| CC
photosensitizing  ||| S:872 E:889 ||| NN
in  ||| S:889 E:892 ||| IN
animal  ||| S:892 E:899 ||| NN
or  ||| S:899 E:902 ||| CC
clinical  ||| S:902 E:911 ||| JJ
tests  ||| S:911 E:917 ||| NNS
but  ||| S:917 E:921 ||| CC
may  ||| S:921 E:925 ||| MD
be  ||| S:925 E:928 ||| VB
mild  ||| S:928 E:933 ||| JJ
ocular  ||| S:933 E:940 ||| JJ
irritants ||| S:940 E:949 ||| NN
.  ||| S:949 E:951 ||| .
The  ||| S:951 E:955 ||| DT
Cosmetic  ||| S:955 E:964 ||| NNP
Ingredient  ||| S:964 E:975 ||| NNP
Review  ||| S:975 E:982 ||| NNP
( ||| S:982 E:983 ||| -LRB-
CIR ||| S:983 E:986 ||| NNP
)  ||| S:986 E:988 ||| -RRB-
Expert  ||| S:988 E:995 ||| NNP
Panel  ||| S:995 E:1001 ||| NNP
concluded  ||| S:1001 E:1011 ||| VBD
that  ||| S:1011 E:1016 ||| IN
these  ||| S:1016 E:1022 ||| DT
ingredients  ||| S:1022 E:1034 ||| NNS
are  ||| S:1034 E:1038 ||| VBP
safe  ||| S:1038 E:1043 ||| JJ
for  ||| S:1043 E:1047 ||| IN
use  ||| S:1047 E:1051 ||| NN
in  ||| S:1051 E:1054 ||| IN
cosmetics  ||| S:1054 E:1064 ||| NNS
in  ||| S:1064 E:1067 ||| IN
the  ||| S:1067 E:1071 ||| DT
practices  ||| S:1071 E:1081 ||| NNS
of  ||| S:1081 E:1084 ||| IN
use  ||| S:1084 E:1088 ||| NN
and  ||| S:1088 E:1092 ||| CC
concentration  ||| S:1092 E:1106 ||| NN
given  ||| S:1106 E:1112 ||| VBN
in  ||| S:1112 E:1115 ||| IN
this  ||| S:1115 E:1120 ||| DT
amended  ||| S:1120 E:1128 ||| JJ
safety  ||| S:1128 E:1135 ||| NN
assessment ||| S:1135 E:1145 ||| NN
.  ||| S:1145 E:1147 ||| .
